Determine the necessary mass, volume, or concentration for preparing a solution.
Litifilimab (anti-CLEC4C) (Ab182759) - ELISA
Immobilized BDCA2-ECD-his at 2.0 μg/mL can bind Litifilimab (anti-CLEC4C) (Ab182759) with the EC
₅₀
of 19.73 ng/mL.
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
Ab182759-100μg | 100μg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $69.90 | |
Ab182759-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $319.90 | |
Ab182759-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $659.90 | |
Ab182759-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,049.90 |
Product Name | Litifilimab (anti-CLEC4C) - Primary antibody, specific to CLEC4C, Human IgG1 |
---|---|
Synonyms | BDCA-2 antibody | BDCA2 antibody | Blood dendritic cell antigen 2 antibody | Blood dendritic cell antigen 2 protein antibody | C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 11 antibody | C-type (calcium dependent, |
Specifications & Purity | RUO, ≥95%(SDS-PAGE&SEC), See COA |
Host species | Human |
Specificity | CLEC4C |
Conjugation | Unconjugated |
Grade | RUO |
Action Type | INHIBITOR |
Mechanism of action | INHIBITOR of C-type lectin domain family 4 member C inhibitor |
Product Description | Litifilimab (anti-CLEC4C) is a humanized IgG1-κ antibody targeting to C-type lectin domain family 4 member C (CLEC4C). Litifilimab (anti-CLEC4C) can be used for cutaneous lupus erythematosus (CLE) study. |
Isotype | Human IgG1 |
---|---|
Light Chain Type | kappa |
SDS-PAGE | 28.0 kDa (Light Chain) & 50.7 kDa (Heavy Chain), under reducing conditions; 204.4 kDa, under non-reducing conditions. |
Purification Method | Protein A purified |
Form | Liquid |
Concentration | See COA |
Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
Shipped In | Ice chest + Ice pads |
Stability And Storage | Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle. |
CAS | 2407378-48-5 |
Litifilimab (anti-CLEC4C) (Ab182759) - ELISA
Immobilized BDCA2-ECD-his at 2.0 μg/mL can bind Litifilimab (anti-CLEC4C) (Ab182759) with the EC
₅₀
of 19.73 ng/mL.
Litifilimab (anti-CLEC4C) (Ab182759) - SEC
The purity of Litifilimab (anti-CLEC4C) (Ab182759) is more than 95% verified by HPLC.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
ZJ24F0607457 | Certificate of Analysis | Jun 28, 2024 | Ab182759 |
ZJ24F0607456 | Certificate of Analysis | Jun 28, 2024 | Ab182759 |
ZJ24F0607455 | Certificate of Analysis | Jun 28, 2024 | Ab182759 |